Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
PJT Partners
PJT
$4.45B
| $13.1M | 0.02% |
256,122
+196,111
| +327% | +$9.67M |
|
1002
PUT
American Airlines Group
AAL
$9.1B
| $13.1M | 0.02% |
1,005,800
+741,800
| +281% | +$9M |
|
1003
Castle Biosciences
CSTL
$1.06B
| $13.1M | 0.02% |
347,928
+138,479
| +66% | +$4.73M |
|
1004
Evercore
EVR
$11.1B
| $13.1M | 0.02% |
221,932
+124,804
| +128% | +$6.79M |
|
1005
Associated Banc-Corp
ASB
$5.82B
| $13.1M | 0.02% |
954,455
+371,062
| +64% | +$5.04M |
|
1006
Rush Street Interactive
RSI
$3.03B
| $13M | 0.02% |
+1,299,680
| New | +$12.7M |
|
|
WPX
1007
DELISTED
WPX Energy, Inc.
WPX
| $13M | 0.02% |
2,043,212
+2,005,531
| +5,322% | +$11.3M |
|
1008
CALL
Analog Devices
ADI
$181B
| $13M | 0.02% |
106,100
+97,700
| +1,163% | +$10.7M |
|
|
RDFN
1009
DELISTED
Redfin
RDFN
| $13M | 0.02% |
310,412
+211,668
| +214% | +$5.58M |
|
1010
ARKO Corp
ARKO
$538M
| $13M | 0.02% |
1,255,999
-294,300
| -19% | -$2.95M |
|
1011
Usana Health Sciences
USNA
$254M
| $13M | 0.02% |
176,716
+155,567
| +736% | +$12.2M |
|
1012
PUT
3M
MMM
$92.7B
| $13M | 0.02% |
99,388
+97,116
| +4,274% | +$12.2M |
|
1013
MGIC Investment
MTG
$6.35B
| $13M | 0.02% |
1,582,796
+1,476,545
| +1,390% | +$11M |
|
1014
Axsome Therapeutics
AXSM
$10.7B
| $12.9M | 0.02% |
157,254
+4,923
| +3% | +$379K |
|
1015
Ally Financial
ALLY
$12.9B
| $12.9M | 0.02% |
652,341
+631,217
| +2,988% | +$10.7M |
|
1016
CVS Health
CVS
$119B
| $12.9M | 0.02% |
199,023
-704,518
| -78% | -$44.4M |
|
1017
AptarGroup
ATR
$8.54B
| $12.9M | 0.02% |
115,287
-1,396
| -1% | -$149K |
|
|
GLUU
1018
DELISTED
Glu Mobile Inc.
GLUU
| $12.9M | 0.02% |
+1,391,111
| New | +$11.8M |
|
|
FOLD
1019
DELISTED
Amicus Therapeutics
FOLD
| $12.9M | 0.02% |
853,323
-404,851
| -32% | -$4.93M |
|
1020
Brown-Forman Class B
BF.B
$12.9B
| $12.8M | 0.02% |
201,754
+193,861
| +2,456% | +$12.4M |
|
1021
Microvast
MVST
$309M
| $12.8M | 0.02% |
1,254,290
| – | – |
|
1022
Kulicke & Soffa
KLIC
$4.41B
| $12.8M | 0.02% |
+613,924
| New | +$13.9M |
|
1023
Syndax Pharmaceuticals
SNDX
$1.79B
| $12.8M | 0.02% |
862,048
+580,957
| +207% | +$8.85M |
|
|
CCXI
1024
DELISTED
ChemoCentryx, Inc.
CCXI
| $12.8M | 0.02% |
221,832
-133,399
| -38% | -$7.26M |
|
1025
Progress Software
PRGS
$1.77B
| $12.7M | 0.02% |
328,286
+47,652
| +17% | +$1.82M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.